A number of research firms have changed their ratings and price targets for Globus Medical (NYSE: GMED): 2/23/2022 – Globus Medical was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 2/22/2022 – Globus Medical was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. […]